Ishmatul Izza, 050610190 (2010) EVALUASI PENGGUNAAN ANTIBIOTIKA CEFPIROME PADA PASIEN RAWAT INAP DI RUMKITAL DR. RAMELAN SURABAYA. Skripsi thesis, UNIVERSITAS AIRLANGGA.

	Text (FULL TEXT) gdlhub-gdl-s1-2011-ishmatuliz-16274-ff0111-e.pdf Restricted to Registered users only Download (1MB) | Request a copy
Preview	Text (ABSTRAK) gdlhub-gdl-s1-2011-ishmatuliz-19511-ff0111-k.pdf Download (135kB) | Preview

Abstract

Cefpirome is a fourth generation cephalosporin that its use should be limited. Cefpirome has a broad antibacterial spectrum, resistance to betalactamase, and rarely cause side effects that are widely used to treat some cases of severe infection. This research is to evaluate the use of cefpirome based on the criteria of rational drug use (awareness of side effects, appropriate patients, appropriate indications, appropriate drug, and appropriate dosage regimentation). Observations retrospectively using medical records of patients receiving cefpirome during their treatment from April 2009 until March 2010. Data collection was performed with a limited sample period. There were 29 patients who fulfilled the inclusion criteria. Cefpirome used in patients with a diagnosis of DHF (44.83%), CKD (10.35%), DM (13.79%), and other diagnoses. Cefpirome be used either alone or in combination with other antibiotics. Only 10.34% patients had received cefpirome therapy rationally

Actions (login required)

View Item